Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional

Journal of Immunology

Volumn 181, Issue 7, 2008, Pages 4507-4515

  Tang, Qin ^a   Grzywacz, Bartosz ^a   Wang, Hongbo ^a   Kataria, Nandini ^c   Cao, Qing ^b   Wagner, John E ^a   Blazar, Bruce R ^a   Miller, Jeffrey S ^a   Verneris, Michael R ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CD3 ANTIGEN; CD3 ZETA ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; FC RECEPTOR; FC RECEPTOR 1 GAMMA; GAMMA INTERFERON; INTERLEUKIN 15; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR P30; NATURAL KILLER CELL RECEPTOR P44; NATURAL KILLER CELL RECEPTOR P46; UNCLASSIFIED DRUG; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NCR3 PROTEIN, HUMAN;

ANTIGEN DETECTION; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL KILLING; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DEGRANULATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; UMBILICAL CORD BLOOD; ADULT; ANIMAL; BIOSYNTHESIS; BLOOD; CELL CULTURE; CELL SEPARATION; COMPARATIVE STUDY; CYTOLOGY; CYTOTOXICITY TEST; FETUS BLOOD; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; NATURAL KILLER T CELL; PHYSIOLOGY; SECRETION; TUMOR CELL LINE;

ADULT; ANIMALS; APOPTOSIS; CELL DEGRANULATION; CELL LINE, TUMOR; CELL SEPARATION; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; FETAL BLOOD; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-15; LYMPHOCYTE ACTIVATION; MICE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER T-CELLS;

EID: 58149308843     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.7.4507     Document Type: Article

References (58)

1. Barker, J. N., and J. E. Wagner. 2003. Umbilical-cord blood transplantation for the treatment of cancer. Nat. Rev. Cancer 3: 526-532. (Pubitemid 37328840)
2. Berry, S. M., N. Fine, J. A. Bichalski, D. B. Cotton, M. P. Dombrowski, and J. Kaplan. 1992. Circulating lymphocyte subsets in second- and third-trimester fetuses: comparison with newborns and adults. Am. J. Obstet. Gynecol. 167: 895-900.
3. Han, P., G. Hodge, C. Story, and X. Xu. 1995. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation. Br. J. Haematol. 89: 733-740.
4. Serrano, L. M., T. Pfeiffer, S. Olivares, T. Numbenjapon, J. Bennitt, D. Kim, D. Smith, G. McNamara, Z. Al-Kadhimi, J. Rosenthal, et al. 2006. Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy. Blood 107: 2643-2652.
5. Kadereit, S., S. F. Mohammad, R. E. Miller, K. D. Woods, C. D. Listrom, K. McKinnon, A. Alali, L. S. Bos, M. L. Iacobucci, M. R. Sramkoski, et al. 1999. Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes. Blood 94: 3101-3107. (Pubitemid 29512716)
6. Kadereit, S., G. R. Junge, T. Kleen, M. M. Kozik, B. A. Kaminski, K. Daum-Woods, P. Fu, M. Tary-Lehmann, and M. J. Laughlin. 2003. Deficient IFN-γ expression in umbilical cord blood (UCB) T cells can be rescued by IFN-γ-mediated increase in NFATc2 expression. J Clin. Immunol. 23: 485-497. (Pubitemid 38180564)
7. + T lymphocytes during primary stimulation. Blood 102: 4608-4617.
8. Pirenne-Ansart, H., F. Paillard, D. De Groote, A. Eljaafari, S. Le Gac, P. Blot, P. Franchimont, C. Vaquero, and G. Sterkers. 1995. Defective cytokine expression but adult-type T-cell receptor, CD8, and p56lck modulation in CD3- or CD2-activated T cells from neonates. Pediatr. Res. 37: 64-69.
9. Chalmers, I. M., G. Janossy, M. Contreras, and C. Navarrete. 1998. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 92: 11-18.
10. Kadereit, S., M. M. Kozik, G. R. Junge, R. E. Miller, L. F. Slivka, L. S. Bos, K. Daum-Woods, R. M. Sramkoski, J. W. Jacobberger, and M. J. Laughlin. 2001. Cyclosporin A effects during primary and secondary activation of human umbilical cord blood T lymphocytes. Exp. Hematol. 29: 903-909. (Pubitemid 32600923)
11. Berthou, C., S. Legros-Maida, A. Soulie, A. Wargnier, J. Guillet, C. Rabian, E. Gluckman, and M. Sasportes. 1995. Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes. Blood 85: 1540-1546.
12. Sato, K., H. Nagayama, and T. A. Takahashi. 1999. Aberrant CD3- and CD28- mediated signaling events in cord blood T cells are associated with dysfunctional regulation of Fas ligand-mediated cytotoxicity. J. Immunol. 162: 4464-4471. (Pubitemid 29314843)
13. Hermann, E., C. Truyens, C. Alonso-Vega, J. Even, P. Rodriguez, A. Berthe, E. Gonzalez-Merino, F. Torrico, and Y. Carlier. 2002. Human fetuses are able to mount an adultlike CD8 T-cell response. Blood 100: 2153-2158. (Pubitemid 35001251)
14. Mommaas, B., J. A. Stegehuis-Kamp, A. G. van Halteren, M. Kester, J. Enczmann, P. Wernet, G. Kogler, T. Mutis, A. Brand, and E. Goulmy. 2005. Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood 105: 1823-1827. (Pubitemid 40223709)
15. + T cells specific for melanocyte differentiation antigens expresses killer inhibitory receptors (KIR) in healthy donors: evidence for a role of KIR in the control of peripheral tolerance. Eur. J. Immunol. 30: 1665-1675.
16. + T cell responses. Nat. Immunol. 3: 189-195.
17. + TCR αβ lymphocytes. Eur. J. Immunol. 34: 3456-3464.
18. Meyers, J. H., A. Ryu, L. Monney, K. Nguyen, E. A. Greenfield, G. J. Freeman, and V. K. Kuchroo. 2002. Cutting edge: CD94/NKG2 is expressed on Th1 but not Th2 cells and costimulates Th1 effector functions. J. Immunol. 169: 5382-5386.
19. + T cells. J. Exp. Med. 197: 437-449.
20. null T cells clonally expanded in rheumatoid arthritis. J. Immunol. 165: 1138-1145.
21. Guma, M., L. K. Busch, L. I. Salazar-Fontana, B. Bellosillo, C. Morte, P. Garcia, and M. Lopez-Botet. 2005. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells. Eur. J. Immunol. 35: 2071-2080. (Pubitemid 41015046)
22. Meresse, B., S. A. Curran, C. Ciszewski, G. Orbelyan, M. Setty, G. Bhagat, L. Lee, M. Tretiakova, C. Semrad, E. Kistner, et al. 2006. Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 203: 1343-1355. (Pubitemid 43736602)
23. + T cells. Blood 103: 3065-3072.
24. Groh, V., R. Rhinehart, J. Randolph-Habecker, M. S. Topp, S. R. Riddell, and T. Spies. 2001. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2: 255-260. (Pubitemid 33706003)
25. + T cells. Proc. Natl. Acad. Sci. USA 95: 1172-1177.
26. Phillips, J. H., J. E. Gumperz, P. Parham, and L. L. Lanier. 1995. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268: 403-405.
27. + T cells. Blood 103: 3065-3072.
28. Roberts, A. I., L. Lee, E. Schwarz, V. Groh, T. Spies, E. C. Ebert, and B. Jabri. 2001. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J. Immunol. 167: 5527-5530.
29. Warren, H. S., P. M. Rana, D. T. Rieger, K. A. Hewitt, J. E. Dahlstrom, and A. L. Kent. 2006. CD8 T cells expressing killer Ig-like receptors and NKG2A are present in cord blood and express a more naive phenotype than their counterparts in adult blood. J. Leukocyte Biol. 79: 1252-1259.
30. Cookson, S., and D. Reen. 2003. IL-15 drives neonatal T cells to acquire CD56 and become activated effector cells. Blood 102: 2195-2197. (Pubitemid 37122398)
31. + effector T cells and limits their proliferative capacity. Eur. J. Immunol. 34: 3413-3422.
32. Ugolini, S., C. Arpin, N. Anfossi, T. Walzer, A. Cambiaggi, R. Forster, M. Lipp, R. E. Toes, C. J. Melief, J. Marvel, and E. Vivier. 2001. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells. Nat. Immunol. 2: 430-435. (Pubitemid 33706141)
33. Jabri, B., J. M. Selby, H. Negulescu, L. Lee, A. I. Roberts, A. Beavis, M. Lopez-Botet, E. C. Ebert, and R. J. Winchester. 2002. TCR specificity dictates CD94/NKG2A expression by human CTL. Immunity 17: 487-499. (Pubitemid 35223537)
34. Miller, J. S., Y. Soignier, A. Panoskaltsis-Mortari, S. A. McNearney, G. H. Yun, S. K. Fautsch, D. McKenna, C. Le, T. E. Defor, L. J. Burns, et al. 2005. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105: 3051-3057. (Pubitemid 40504320)
35. Dudley, M. E., J. R. Wunderlich, J. C. Yang, R. M. Sherry, S. L. Topalian, N. P. Restifo, R. E. Royal, U. Kammula, D. E. White, S. A. Mavroukakis, et al. 2005. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 23: 2346-2357.
36. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19: 197-223. (Pubitemid 32368034)
37. Sato, M., J. Ohashi, N. Tsuchiya, K. Tadokoro, T. Juji, K. Hanaoka, K. Tokunaga, and T. Yabe. 2001. Identification of novel single nucleotide substitutions in the NKp30 gene expressed in human natural killer cells. Tissue Antigens 58: 255-258. (Pubitemid 34015429)
38. Vitale, M., C. Bottino, S. Sivori, L. Sanseverino, R. Castriconi, E. Marcenaro, R. Augugliaro, L. Moretta, and A. Moretta. 1998. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187: 2065-2072. (Pubitemid 28285576)
39. Cantoni, C., C. Bottino, M. Vitale, A. Pessino, R. Augugliaro, A. Malaspina, S. Parolini, L. Moretta, A. Moretta, and R. Biassoni. 1999. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J. Exp. Med. 189: 787-796. (Pubitemid 29189683)
40. Sivori, S., D. Pende, C. Bottino, E. Marcenaro, A. Pessino, R. Biassoni, L. Moretta, and A. Moretta. 1999. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells: correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 29: 1656-1666. (Pubitemid 29224471)
41. Sivori, S., M. Vitale, L. Morelli, L. Sanseverino, R. Augugliaro, C. Bottino, L. Moretta, and A. Moretta. 1997. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J. Exp. Med. 186: 1129-1136. (Pubitemid 27441156)
42. + cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J. Immunol. 153: 1687-1696.
43. Rubio, V., T. B. Stuge, N. Singh, M. R. Betts, J. S. Weber, M. Roederer, and P. P. Lee. 2003. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med. 9: 1377-1382. (Pubitemid 37466186)
44. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181: 71-77.
45. Poggi, A., A. M. Massaro, S. Negrini, P. Contini, and M. R. Zocchi. 2005. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors. J. Immunol. 174: 2653-2660. (Pubitemid 40279679)
46. + T cells closely correlates with CD56 surface expression. J. Immunol. 164: 1148-1152.
47. Meresse, B., Z. Chen, C. Ciszewski, M. Tretiakova, G. Bhagat, T. N. Krausz, D. H. Raulet, L. L. Lanier, V. Groh, T. Spies, et al. 2004. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21: 357-366. (Pubitemid 39208337)
48. Pende, D., S. Parolini, A. Pessino, S. Sivori, R. Augugliaro, L. Morelli, E. Marcenaro, L. Accame, A. Malaspina, R. Biassoni, et al. 1999. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190: 1505-1516.
49. Augugliaro, R., S. Parolini, R. Castriconi, E. Marcenaro, C. Cantoni, M. Nanni, L. Moretta, A. Moretta, and C. Bottino. 2003. Selective cross-talk among natural cytotoxicity receptors in human natural killer cells. Eur. J. Immunol. 33: 1235-1241. (Pubitemid 36609141)
50. + effector and memory T cell generation. Nat Immunol. 4: 835-842.
51. + NK T and γδ T cells from cord blood of human neonates. Clin. Exp. Immunol. 113: 220-228.
52. Pessino, A., S. Sivori, C. Bottino, A. Malaspina, L. Morelli, L. Moretta, R. Biassoni, and A. Moretta. 1998. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 188: 953-960. (Pubitemid 28433421)
53. Vitale, M., C. Bottino, S. Sivori, L. Sanseverino, R. Castriconi, E. Marcenaro, R. Augugliaro, L. Moretta, and A. Moretta. 1998. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187: 2065-2072. (Pubitemid 28285576)
54. Chisholm, S. E., and H. T. Reyburn. 2006. Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J. Virol. 80: 2225-2233.
55. Fuller, C. L., G. Ruthel, K. L. Warfield, D. L. Swenson, C. M. Bosio, M. J. Aman, and S. Bavari. 2007. NKp30-dependent cytolysis of filovirus-infected human dendritic cells. Cell. Microbiol. 9: 962-976. (Pubitemid 46394907)
56. Chisholm, S. E., K. Howard, M. V. Gomez, and H. T. Reyburn. 2007. Expression of ICP0 is sufficient to trigger natural killer cell recognition of herpes simplex virus-infected cells by natural cytotoxicity receptors. J. Infect. Dis. 195: 1160-1168.
57. Meresse, B., S. A. Curran, C. Ciszewski, G. Orbelyan, M. Setty, G. Bhagat, L. Lee, M. Tretiakova, C. Semrad, E. Kistner, et al. 2006. Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 203: 1343-1355. (Pubitemid 43736602)
58. Guy-Grand, D., B. Rocha, P. Mintz, M. Malassis-Seris, F. Selz, B. Malissen, and P. Vassalli. 1994. Different use of T cell receptor transducing modules in two populations of gut intraepithelial lymphocytes are related to distinct pathways of T cell differentiation. J. Exp. Med. 180: 673-679. (Pubitemid 24224144)